Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Evaluation of the Economic Burden of Psoriatic Arthritis and the Relationship Between Functional Status and Healthcare Costs.

McHugh N, Maguire Á, Handel I, Tillett W, Morris J, Hawkins N, Cavill C, Korendowych E, Mughal F.

J Rheumatol. 2019 Aug 15. pii: jrheum.190083. doi: 10.3899/jrheum.190083. [Epub ahead of print]

PMID:
31416922
2.

Psoriatic Nail Dystrophy Is Associated with Erosive Disease in the Distal Interphalangeal Joints in Psoriatic Arthritis: A Retrospective Cohort Study.

Antony AS, Allard A, Rambojun A, Lovell CR, Shaddick G, Robinson G, Jadon DR, Holland R, Cavill C, Korendowych E, McHugh NJ, Tillett W.

J Rheumatol. 2019 Sep;46(9):1097-1102. doi: 10.3899/jrheum.180796. Epub 2019 Mar 1.

PMID:
30824637
3.

Trajectory of radiographic change over a decade: the effect of transition from conventional synthetic disease-modifying antirheumatic drugs to anti-tumour necrosis factor in patients with psoriatic arthritis.

Allard A, Antony A, Shaddick G, Jadon DR, Cavill C, Robinson G, Korendowych E, McHugh N, Tillett W.

Rheumatology (Oxford). 2019 Feb 1;58(2):269-273. doi: 10.1093/rheumatology/key297.

PMID:
30247726
4.

Assessment of two screening tools to identify psoriatic arthritis in patients with psoriasis.

Coates LC, Savage LJ, Chinoy H, Laws PM, Lovell CR, Korendowych E, Mahmood F, Mathieson HR, McGonagle D, Warren RB, Waxman R, Helliwell PS.

J Eur Acad Dermatol Venereol. 2018 Sep;32(9):1530-1534. doi: 10.1111/jdv.14971. Epub 2018 May 9.

5.

Morphoea profunda and its relationship to eosinophilic fasciitis.

Wlodek C, Korendowych E, McHugh N, Lovell CR.

Clin Exp Dermatol. 2018 Apr;43(3):306-310. doi: 10.1111/ced.13353. Epub 2017 Dec 26.

PMID:
29277925
6.

Validation of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire and its potential as a single-item outcome measure in clinical practice.

Holland R, Tillett W, Korendowych E, Cavill C, Waldron N, Brooke M, McHugh NJ.

Ann Rheum Dis. 2018 Mar;77(3):343-347. doi: 10.1136/annrheumdis-2017-211996. Epub 2017 Nov 16.

PMID:
29146740
7.

Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study.

Jadon DR, Sengupta R, Nightingale A, Lu H, Dunphy J, Green A, Elder JT, Nair RP, Korendowych E, Lindsay MA, McHugh NJ.

Arthritis Res Ther. 2017 Sep 21;19(1):210. doi: 10.1186/s13075-017-1417-7.

8.

Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis.

Bowes J, Ashcroft J, Dand N, Jalali-Najafabadi F, Bellou E, Ho P, Marzo-Ortega H, Helliwell PS, Feletar M, Ryan AW, Kane DJ, Korendowych E, Simpson MA, Packham J, McManus R, Brown MA, Smith CH, Barker JN, McHugh N, FitzGerald O, Warren RB, Barton A.

Ann Rheum Dis. 2017 Oct;76(10):1774-1779. doi: 10.1136/annrheumdis-2017-211414. Epub 2017 Aug 18.

9.

A rare coding allele in IFIH1 is protective for psoriatic arthritis.

Budu-Aggrey A, Bowes J, Stuart PE, Zawistowski M, Tsoi LC, Nair R, Jadon DR, McHugh N, Korendowych E, Elder JT, Barton A, Raychaudhuri S.

Ann Rheum Dis. 2017 Jul;76(7):1321-1324. doi: 10.1136/annrheumdis-2016-210592. Epub 2017 May 13.

10.

A new era for collaboration?

Packham JC, Abraham S, Kirkham B, Helliwell P, Siebert S, Korendowych E, Fitzgerald O, Parkinson A, Brookes M, Coates L, McHugh N.

Rheumatology (Oxford). 2018 May 1;57(5):775-776. doi: 10.1093/rheumatology/kex083. No abstract available.

PMID:
28407115
11.

Effect of anti-TNF and conventional synthetic disease-modifying anti-rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritis.

Tillett W, Shaddick G, Jobling A, Askari A, Cooper A, Creamer P, Clunie G, Helliwell PS, James J, Kay L, Korendowych E, Lane S, Packham J, Shaban R, Thomas ML, Williamson L, McHugh N.

Rheumatology (Oxford). 2017 Apr 1;56(4):603-612. doi: 10.1093/rheumatology/kew433.

PMID:
28013211
12.

Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis.

Jadon DR, Sengupta R, Nightingale A, Lindsay M, Korendowych E, Robinson G, Jobling A, Shaddick G, Bi J, Winchester R, Giles JT, McHugh NJ.

Ann Rheum Dis. 2017 Apr;76(4):701-707. doi: 10.1136/annrheumdis-2016-209853. Epub 2016 Dec 2.

13.

Replication of a distinct psoriatic arthritis risk variant at the IL23R locus.

Budu-Aggrey A, Bowes J, Loehr S, Uebe S, Zervou MI, Helliwell P, Ryan AW, Kane D, Korendowych E, Giardina E, Packham J, McManus R, FitzGerald O, McHugh N, Behrens F, Burkhardt H, Huffmeier U, Ho P, Martin J, Castañeda S, Goulielmos G, Reis A, Barton A.

Ann Rheum Dis. 2016 Jul;75(7):1417-8. doi: 10.1136/annrheumdis-2016-209290. Epub 2016 Mar 25. Review. No abstract available.

14.

Novel Composite Radiographic Score for Longitudinal Observational Studies of Psoriatic Arthritis: A Proof-of-concept Study.

Tillett W, Shaddick G, Jadon D, Robinson G, Korendowych E, McHugh N.

J Rheumatol. 2016 Feb;43(2):367-70. doi: 10.3899/jrheum.150114. Epub 2016 Jan 15. Erratum in: J Rheumatol. 2017 Oct;44(10):1568.

PMID:
26773116
15.

Corrigendum: Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis.

Bowes J, Budu-Aggrey A, Huffmeier U, Uebe S, Steel K, Hebert HL, Wallace C, Massey J, Bruce IN, Bluett J, Feletar M, Morgan AW, Marzo-Ortega H, Donohoe G, Morris DW, Helliwell P, Ryan AW, Kane D, Warren RB, Korendowych E, Alenius GM, Giardina E, Packham J, McManus R, FitzGerald O, McHugh N, Brown MA, Ho P, Behrens F, Burkhardt H, Reis A, Barton A.

Nat Commun. 2015 Jul 6;6:7741. doi: 10.1038/ncomms8741. No abstract available.

16.

Psoriatic Arthritis Mutilans: Characteristics and Natural Radiographic History.

Jadon DR, Shaddick G, Tillett W, Korendowych E, Robinson G, Waldron N, Cavill C, McHugh NJ.

J Rheumatol. 2015 Jul;42(7):1169-76. doi: 10.3899/jrheum.150083. Epub 2015 May 15.

PMID:
25979723
17.

PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locus.

Bowes J, Loehr S, Budu-Aggrey A, Uebe S, Bruce IN, Feletar M, Marzo-Ortega H, Helliwell P, Ryan AW, Kane D, Korendowych E, Alenius GM, Giardina E, Packham J, McManus R, FitzGerald O, Brown MA, Behrens F, Burkhardt H, McHugh N, Huffmeier U, Ho P, Reis A, Barton A.

Ann Rheum Dis. 2015 Oct;74(10):1882-5. doi: 10.1136/annrheumdis-2014-207187. Epub 2015 Apr 28.

18.

Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis.

Bowes J, Budu-Aggrey A, Huffmeier U, Uebe S, Steel K, Hebert HL, Wallace C, Massey J, Bruce IN, Bluett J, Feletar M, Morgan AW, Marzo-Ortega H, Donohoe G, Morris DW, Helliwell P, Ryan AW, Kane D, Warren RB, Korendowych E, Alenius GM, Giardina E, Packham J, McManus R, FitzGerald O, McHugh N, Brown MA, Ho P, Behrens F, Burkhardt H, Reis A, Barton A.

Nat Commun. 2015 Feb 5;6:6046. doi: 10.1038/ncomms7046. Erratum in: Nat Commun. 2015;6:7741.

19.

Serum soluble bone turnover biomarkers in psoriatic arthritis and psoriatic spondyloarthropathy.

Jadon DR, Nightingale AL, McHugh NJ, Lindsay MA, Korendowych E, Sengupta R.

J Rheumatol. 2015 Jan;42(1):21-30. doi: 10.3899/jrheum.140223. Epub 2014 Nov 1. Review.

PMID:
25362660
20.

Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre study.

Tillett W, Shaddick G, Askari A, Cooper A, Creamer P, Clunie G, Helliwell PS, Kay L, Korendowych E, Lane S, Packham J, Shaban R, Williamson L, McHugh N.

Rheumatology (Oxford). 2015 Jan;54(1):157-62. doi: 10.1093/rheumatology/keu264. Epub 2014 Aug 13.

PMID:
25125591
21.

Abnormal cardiac enzymes in systemic sclerosis: a report of four patients and review of the literature.

Vasta B, Flower V, Bucciarelli-Ducci C, Brown S, Korendowych E, McHugh NJ, Pauling JD.

Clin Rheumatol. 2014 Mar;33(3):435-8. doi: 10.1007/s10067-013-2405-1. Epub 2013 Oct 3. Review.

PMID:
24091585
22.

Disease assessment in psoriatic spectrum: a modular approach for use in routine clinical practice.

Wajed J, Helliwell P, Korendowych E, Gadsby K, Oliver S, Parrish L, Kirkham B.

Ann Rheum Dis. 2014 Jan;73(1):318-9. doi: 10.1136/annrheumdis-2013-203798. Epub 2013 Aug 30. No abstract available.

PMID:
23994863
23.

Feasibility, reliability, and sensitivity to change of four radiographic scoring methods in patients with psoriatic arthritis.

Tillett W, Jadon D, Shaddick G, Robinson G, Sengupta R, Korendowych E, de Vries CS, McHugh NJ.

Arthritis Care Res (Hoboken). 2014 Feb;66(2):311-7. doi: 10.1002/acr.22104.

24.

The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics.

Coates LC, Tillett W, Chandler D, Helliwell PS, Korendowych E, Kyle S, McInnes IB, Oliver S, Ormerod A, Smith C, Symmons D, Waldron N, McHugh NJ; BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR.

Rheumatology (Oxford). 2013 Oct;52(10):1754-7. doi: 10.1093/rheumatology/ket187. Epub 2013 Jul 25. No abstract available.

PMID:
23887065
25.

Variants in RUNX3 contribute to susceptibility to psoriatic arthritis, exhibiting further common ground with ankylosing spondylitis.

Apel M, Uebe S, Bowes J, Giardina E, Korendowych E, Juneblad K, Pasutto F, Ekici AB, McManus R, Ho P, Bruce IN, Ryan AW, Behrens F, Böhm B, Traupe H, Lohmann J, Gieger C, Wichmann HE, Padyukov L, Fitzgerald O, Alenius GM, McHugh NJ, Novelli G, Burkhardt H, Barton A, Reis A, Hüffmeier U.

Arthritis Rheum. 2013 May;65(5):1224-31. doi: 10.1002/art.37885.

26.

Ustekinumab for resistant psoriatic arthritis.

Wallis DE, Waldron NM, Korendowych E.

J Rheumatol. 2013 Feb;40(2):207. doi: 10.3899/jrheum.121152. No abstract available.

PMID:
23378500
27.

Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis.

Tillett W, Jadon D, Shaddick G, Cavill C, Korendowych E, de Vries CS, McHugh N.

Ann Rheum Dis. 2013 Aug;72(8):1358-61. doi: 10.1136/annrheumdis-2012-202608. Epub 2013 Jan 3.

PMID:
23291384
28.

Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritis.

Jadon D, Tillett W, Wallis D, Cavill C, Bowes J, Waldron N, Dixon A, Sengupta R, Barton A, Korendowych E, McHugh NJ.

Rheumatology (Oxford). 2013 Feb;52(2):261-6. doi: 10.1093/rheumatology/kes254. Epub 2012 Oct 23.

PMID:
23093722
29.

Joint count reliability in psoriatic arthritis observational trials--an unreported problem.

Tillett W, Shaddick G, Korendowych E, de Vries CS, McHugh N.

Rheumatology (Oxford). 2012 Jul;51(7):1333-4. doi: 10.1093/rheumatology/kes095. Epub 2012 May 4. No abstract available.

30.

Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort.

Bowes J, Ho P, Flynn E, Ali F, Marzo-Ortega H, Coates LC, Warren RB, McManus R, Ryan AW, Kane D, Korendowych E, McHugh N, FitzGerald O, Packham J, Morgan AW, Bruce IN, Barton A.

Ann Rheum Dis. 2012 Aug;71(8):1350-4. doi: 10.1136/annrheumdis-2011-200802. Epub 2012 Feb 10.

31.

Tumor necrosis factor promoter polymorphism TNF*-857 is a risk allele for psoriatic arthritis independent of the PSORS1 locus.

Giardina E, Hüffmeier U, Ravindran J, Behrens F, Lepre T, McHugh NJ, Korendowych E, Burkhardt H, Novelli G, Reis A.

Arthritis Rheum. 2011 Dec;63(12):3801-6. doi: 10.1002/art.30591.

32.

The ClASsification for Psoriatic ARthritis (CASPAR) criteria--a retrospective feasibility, sensitivity, and specificity study.

Tillett W, Costa L, Jadon D, Wallis D, Cavill C, McHugh J, Korendowych E, McHugh N.

J Rheumatol. 2012 Jan;39(1):154-6. doi: 10.3899/jrheum.110845. Epub 2011 Nov 15.

PMID:
22089469
33.

Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis.

Bowes J, Orozco G, Flynn E, Ho P, Brier R, Marzo-Ortega H, Coates L, McManus R, Ryan AW, Kane D, Korendowych E, McHugh N, FitzGerald O, Packham J, Morgan AW, Bruce IN, Barton A.

Ann Rheum Dis. 2011 Sep;70(9):1641-4. doi: 10.1136/ard.2011.150102. Epub 2011 May 29.

34.

Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris.

Bowes J, Eyre S, Flynn E, Ho P, Salah S, Warren RB, Marzo-Ortega H, Coates L, McManus R, Ryan AW, Kane D, Korendowych E, McHugh N, FitzGerald O, Packham J, Morgan AW, Griffiths CE, Bruce IN, Worthington J, Barton A.

Ann Rheum Dis. 2011 Jun;70(6):1016-9. doi: 10.1136/ard.2010.143123. Epub 2011 Feb 23.

35.

Vacuum-assisted closure therapy: a novel treatment for wound healing in systemic sclerosis.

Pauling JD, Brown SJ, James J, Shipley JA, Korendowych E, McHugh NJ.

Rheumatology (Oxford). 2011 Feb;50(2):420-2. doi: 10.1093/rheumatology/keq319. Epub 2010 Oct 19. No abstract available.

PMID:
20959357
36.

Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis.

Hüffmeier U, Uebe S, Ekici AB, Bowes J, Giardina E, Korendowych E, Juneblad K, Apel M, McManus R, Ho P, Bruce IN, Ryan AW, Behrens F, Lascorz J, Böhm B, Traupe H, Lohmann J, Gieger C, Wichmann HE, Herold C, Steffens M, Klareskog L, Wienker TF, Fitzgerald O, Alenius GM, McHugh NJ, Novelli G, Burkhardt H, Barton A, Reis A.

Nat Genet. 2010 Nov;42(11):996-9. doi: 10.1038/ng.688. Epub 2010 Oct 17.

37.

Mortality in psoriatic arthritis - a single-center study from the UK.

Buckley C, Cavill C, Taylor G, Kay H, Waldron N, Korendowych E, McHugh N.

J Rheumatol. 2010 Oct;37(10):2141-4. doi: 10.3899/jrheum.100034. Epub 2010 Aug 3.

PMID:
20682670
38.

Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritis.

Bowes J, Flynn E, Ho P, Aly B, Morgan AW, Marzo-Ortega H, Coates L, McManus R, Ryan AW, Kane D, Korendowych E, McHugh N, FitzGerald O, Packham J, Bruce IN, Barton A.

Ann Rheum Dis. 2010 Dec;69(12):2199-203. doi: 10.1136/ard.2010.130575. Epub 2010 Jul 19.

39.

A modified Sharp score demonstrates disease progression in established psoriatic arthritis.

Ravindran J, Cavill C, Balakrishnan C, Jones SM, Korendowych E, McHugh NJ.

Arthritis Care Res (Hoboken). 2010 Jan 15;62(1):86-91. doi: 10.1002/acr.20018.

40.

Drug use and toxicity in psoriatic disease: focus on methotrexate.

Taylor WJ, Korendowych E, Nash P, Helliwell PS, Choy E, Krueger GG, Soriano ER, McHugh NJ, Rosen CF.

J Rheumatol. 2008 Jul;35(7):1454-7.

PMID:
18609744
41.

Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus.

Chan MT, Owen P, Dunphy J, Cox B, Carmichael C, Korendowych E, McHugh NJ.

J Rheumatol. 2008 Jan;35(1):77-83. Epub 2007 Dec 15.

PMID:
18085741
42.

Genetic factors in psoriatic arthritis.

Korendowych E, McHugh N.

Curr Rheumatol Rep. 2005 Aug;7(4):306-12. Review.

PMID:
16045834
43.

The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis.

Korendowych E, Owen P, Ravindran J, Carmichael C, McHugh N.

Rheumatology (Oxford). 2005 Aug;44(8):1056-60. Epub 2005 May 18.

PMID:
15901902
44.

Interleukin 1alpha, interleukin 1beta and interleukin 1 receptor gene polymorphisms in psoriatic arthritis.

Ravindran JS, Owen P, Lagan A, Lewis J, Korendowych E, Welsh K, McHugh N.

Rheumatology (Oxford). 2004 Jan;43(1):22-6. Epub 2003 Jul 30.

PMID:
12890860
45.

Hypothalamo-pituitary-adrenal axis dysregulation in patients with rheumatoid arthritis after the dexamethasone/corticotrophin releasing factor test.

Harbuz MS, Korendowych E, Jessop DS, Crown AL, Li pdfan SL, Kirwan JR.

J Endocrinol. 2003 Jul;178(1):55-60.

PMID:
12844336
46.
47.

Patient-initiated hospital follow-up for rheumatoid arthritis.

Hewlett S, Mitchell K, Haynes J, Paine T, Korendowych E, Kirwan JR.

Rheumatology (Oxford). 2000 Sep;39(9):990-7.

PMID:
10986304

Supplemental Content

Loading ...
Support Center